Page 31 Volume 13 - N.2 - 2005

Dor (2005) 13
Bibliografia 11. Hosobuchi Y, Adams JE, Rutkins B. Chronic thalamic stimulation for the
control of facial anesthesia dolorosa. Arch Neurol 1973;29:158-61.
1. Starr PA, Vitek JL, Bakay RAE. Ablative surgery and deep 12. Mazars G, Merienne L, Ciolocca C. Stimulations thalamiques inter-
brain stimulation for Parkinson’s disease. Neurosurg 1998;43(5): mittentes antalgiques. Note preliminaire. Rev Neurol (Paris) 1973;
989-1013. 128:273-9.
2. Germano I. Neurosurgical treatment of movement disorders. Neuro- 13. Levy RM. Deep brain stimulation for the treatment of intractable pain.
surgical topics. Neurosurg Clin N Am 2003;14:389-99.
3. Robbins & Cotran. Pathologic basis of diseases. Vinay Kumar, et al. 14. Young RF, Rinaldi PC. Brain stimulation in pain. Em: Levy RM, North RB,
Saunders 2004. editores. The neurosurgery of chronic pain. New York: Springer-Verlag.
4. Jankovic J. Complications and limitations of drug therapy for Par- 15. Rasmussen AS, Eisen JL. The epidemiology and clinical features
kinson’s disease. Neurology 2000;55(12 suppl 6):S2-6. of obcessive compulsive disorder. Psychiatr Clin North Am 1992;
5. Nohric V, Partiot A. A review of the efficacy of the dopamine agonists 15:743-58.
pergolide and bromocriptine in the treatment of Parkinson’s disease. 16. Greenberg BD, et al. Neurosurgery for intractable obsessive-com-
Europ J Neurol 1997;4:537-43. pulsive disorder and depression: critical issues. Neurosurg Clin N
6. Hallett M, Litvan I, Task Force for Parkinson’s Disease. Evaluation of Am 2003;14:199-212.
surgery for Parkinson’s disease – a report of the therapeutics and 17. Lehtinen V, Joukamaa M. Epidemiology of depression: prevalence,
technology assessement subcommitte of the American Academy of risk factores and treatment situation. Acta Psychiatric Scand Suppl
Neurology. Neurology 1999;53:1910-21. 1994;377:7-10.
7. Benabid A, Benazzus A, Gao D, Hoffman D, Limousin P, et al. 18. Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from
Chronic electrical stimulation of the ventralis intermedius nucleus of major depressive disorder during 15 years of observational follow-up.
the thalamus and other nuclei as a treatment for Parkinson’s disease. Am J Psychiatry 1999;156:1000-6.
Techniques in Neurosurgery 1999;5. 19. Fava M, Davidson KG. Definition and epidemiology of treatment-
8. Alkhani A, Lozano A. Pallidotomy for Parkinson’s disease: a review resistent depression. Psychiatr Clin North Am 1996;19:179-200.
of contemporary literature. J Neurosurg 2001:94:43-9. 20. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, et al. Electri-
9. Heath RG. Studies in schizophrenia. Cambridge, MA: Harvard Uni- cal stimulation of the subthalamic nucleus in advanced Parkinson’s
versity Press; 1954. disease. N Engl J Med 1998;339:1105-11.
10. Richardson DE, Akil H. Pain reduction by electical brain stimulation 21. Krack P, Pollak P, Benazzouz A, Benabid A, Pollak P. Five year fol-
in man. Part 1: acute administration in periaqueductal and periven- low-up of bilateral stimulation of the subthalamic nucleus in ad-
tricular sites. J Neurosurg 1977;47:178-83. vanced Parkinson’s disease. N Engl J Med 2003;349:1925-34.

DOR

30